Literature DB >> 21968106

There's a goat behind door number 3: from Monty Hall to medicine.

David J Friedman1, Laurence A Turka, Simon C Robson.   

Abstract

In the 18th century, Thomas Bayes developed his eponymous theorem that teaches us that pretest probabilities can be altered by new information, such as when game show host Monty Hall revealed the goat behind one of the remaining doors in "Let's Make A Deal." Bayesian analysis is a key feature of many medical decisions. In this issue of the JCI, Lee and colleagues apply this concept to inflammatory bowel disease to identify gene expression-based biomarkers of disease severity. Importantly, these biomarkers allowed patients to be stratified into two groups: those at high risk for disease recurrence or the need for immunosuppressive treatment escalation and those with a more benign disease course.

Entities:  

Mesh:

Year:  2011        PMID: 21968106      PMCID: PMC3195486          DOI: 10.1172/JCI60003

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  12 in total

Review 1.  The genetics of inflammatory bowel disease.

Authors:  Denise K Bonen; Judy H Cho
Journal:  Gastroenterology       Date:  2003-02       Impact factor: 22.682

Review 2.  Genetics and pathogenesis of inflammatory bowel disease.

Authors:  Bernard Khor; Agnès Gardet; Ramnik J Xavier
Journal:  Nature       Date:  2011-06-15       Impact factor: 49.962

Review 3.  The fundamental basis of inflammatory bowel disease.

Authors:  Warren Strober; Ivan Fuss; Peter Mannon
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

Review 4.  Autoimmune diseases: insights from genome-wide association studies.

Authors:  Guillaume Lettre; John D Rioux
Journal:  Hum Mol Genet       Date:  2008-10-15       Impact factor: 6.150

Review 5.  Th17 T cells: linking innate and adaptive immunity.

Authors:  Brigitta Stockinger; Marc Veldhoen; Bruno Martin
Journal:  Semin Immunol       Date:  2007-11-26       Impact factor: 11.130

Review 6.  The genetics of autoimmune diseases: a networked perspective.

Authors:  Sergio E Baranzini
Journal:  Curr Opin Immunol       Date:  2009-11-05       Impact factor: 7.486

7.  Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C.

Authors:  Yasuhito Tanaka; Nao Nishida; Masaya Sugiyama; Masayuki Kurosaki; Kentaro Matsuura; Naoya Sakamoto; Mina Nakagawa; Masaaki Korenaga; Keisuke Hino; Shuhei Hige; Yoshito Ito; Eiji Mita; Eiji Tanaka; Satoshi Mochida; Yoshikazu Murawaki; Masao Honda; Akito Sakai; Yoichi Hiasa; Shuhei Nishiguchi; Asako Koike; Isao Sakaida; Masatoshi Imamura; Kiyoaki Ito; Koji Yano; Naohiko Masaki; Fuminaka Sugauchi; Namiki Izumi; Katsushi Tokunaga; Masashi Mizokami
Journal:  Nat Genet       Date:  2009-09-13       Impact factor: 38.330

8.  Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer.

Authors:  Jenny C Chang; Eric C Wooten; Anna Tsimelzon; Susan G Hilsenbeck; M Carolina Gutierrez; Richard Elledge; Syed Mohsin; C Kent Osborne; Gary C Chamness; D Craig Allred; Peter O'Connell
Journal:  Lancet       Date:  2003-08-02       Impact factor: 79.321

9.  Gene expression profiling of CD8+ T cells predicts prognosis in patients with Crohn disease and ulcerative colitis.

Authors:  James C Lee; Paul A Lyons; Eoin F McKinney; John M Sowerby; Edward J Carr; Francesca Bredin; Hannah M Rickman; Huzefa Ratlamwala; Alexander Hatton; Tim F Rayner; Miles Parkes; Kenneth G C Smith
Journal:  J Clin Invest       Date:  2011-09-26       Impact factor: 14.808

10.  A CD8+ T cell transcription signature predicts prognosis in autoimmune disease.

Authors:  Eoin F McKinney; Paul A Lyons; Edward J Carr; Jane L Hollis; David R W Jayne; Lisa C Willcocks; Maria Koukoulaki; Alvis Brazma; Vojislav Jovanovic; D Michael Kemeny; Andrew J Pollard; Paul A Macary; Afzal N Chaudhry; Kenneth G C Smith
Journal:  Nat Med       Date:  2010-04-18       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.